Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Yifan Pharmaceutical Co Ltd

002019.SZ ✓ COMPLIANT ☆ Track — members

SZSE · Healthcare · Pharmaceuticals ·

China Small Cap Analyst: BUY

Last Close

$1.46

▼ -2.86%

Market Cap $1.78B · Vol 16.68M

Key Metrics

P/E Ratio

33.57

FWD: 13.69

Market Cap

$1.78B

Small Cap

Div Yield

1.02%

Annual dividend

EPS Growth

+87.99%

YoY

RSI (14)

41.41

Momentum

Beta

0.76

vs Market

52W High

$2.46

36.67% below

52W Low

$1.35

9.65% above

Volume

16.68M

Avg 17.75M

P/B

1.62

Price-to-book

ROE

4.57%

Return on equity

Free Float

53.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Yifan Pharmaceutical Co Ltd (002019.SZ) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 002019.SZ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.93%

+0.41%

-4.47%

-19.01%

YTD

-17.73%

-38.73%

-14.30%

-34.92%

Financials & Valuation

TTM · Annual

Total Revenue	$734.00M
Net Income	$53.40M
Revenue Growth (YoY)	-1.07%
Gross Margin	46.30%
Operating Margin	9.66%
Net Profit Margin	7.28%
ROE	4.57%
ROA · ROIC	3.37% · 4.07%

P/E Ratio	33.57
Forward P/E (FY1)	13.69
PEG Ratio	11.60
P/S	2.84
P/B	1.62
P/FCF	N/A
EPS Growth	+87.99%
Outstanding Shares	1.22B

Technical Indicators

50-Day SMA	$1.50
200-Day SMA	$1.74
RSI (14)	41.41
Beta	0.76
52-Week High	$2.46
52-Week Low	$1.35

Volume Today	16.68M
Avg Daily Volume (30D)	17.75M
Relative Volume	0.94x
Volatility (10D)	44.08
Volatility (30D)	42.32
Free Float	53.36%

Analyst Consensus

BUY

Current Price $1.46

Mean Target N/A

52W Low$1.35 52W High$2.46

Current

Target

$1.35 $2.46

Current Analyst target

· 1 analysts

Identifiers

ExchangeSZSE

FIGIBBG001SM2BK9

ISINCNE000001K65

CountryChina

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.67% JNJ Johnson & Johnson +1.04% ABBV Abbvie Inc -0.17% NVS Novartis AG -0.53% NOVN.S Novartis AG -0.52%

Company Profile

Yifan Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production, sales and pharmaceutical promotion services of pharmaceutical products, active pharmaceutical ingredient and polymer materials. The Company conducts business through two segments. The Pharmaceutical Products segment mainly produces Chinese patent medicines, chemical drugs and biological drugs. Its products include Child Qingqiao Granules, Skin Allery Relieving Capsules, lactulose oral solution and granulocyte colony stimulating factor. The Pharmaceutical Raw Materials and Polymers segment mainly produces active pharmaceutical ingredient, and its products are mainly vitamin B5 and pro-B5. The Company mainly conducts business in domestic and foreign markets.